MedTech Dive September 20, 2021
Greg Slabodkin

Dive Brief:

  • The U.K.’s Medicines and Healthcare products Regulatory Agency is overhauling its regulations applying to software and artificial intelligence as a medical device.
  • MHRA has developed a Software and AI as a Medical Device Change Programme it contends will provide a regulatory framework that will ensure “the U.K. is the home of responsible innovation.” The U.K. device regulator is seeking changes across the software as a medical device lifecycle, from qualification to classification to pre- and post-market requirements.
  • The overhaul comes as the FDA issued its own action plan in January for establishing a regulatory approach to such software. Bradley Merrill Thompson, attorney at the law firm Epstein Becker Green, contends that MHRA is a “small step”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Govt Agencies, Health IT, Medical Devices, Regulations, Technology
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Bayer and ASPIVIX collaborate on women’s health device
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Brain-computer interface research reaches new frontiers
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements

Share This Article